A Study to Evaluate ALN-AGT01 RVR in Adult Patients With Mild to Moderate Hypertension Pretreated With Zilebesiran

NCT07553442 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

93

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: ALN-AGT01 RVR
DRUG: Placebo
DRUG: Zilebesiran

Sponsor

Alnylam Pharmaceuticals

Collaborators

Hoffmann-La Roche